Changing Outcomes of Pulmonary Artery Banding With the Percutaneously Adjustable Pulmonary Artery Band

Transcatheter balloon angioplasty of internal pulmonary artery bands to improve pulmonary blood flow: a case series

Pulmonary artery banding (PAB) is used to restrict pulmonary blood flow in select patients with large left-to-right intracardiac shunts or unrestrictive pulmonary blood flow prior to eventual surgical repair or palliation. More recently, surgical placement of an internal or intraluminal PAB (IPAB) has been used to restrict pulmonary circulation. Here we present two patients who underwent balloon angioplasty of the IPAB to treat cyanosis and improve pulmonary blood flow.

Mid-term outcomes of patients undergoing adjustable pulmonary artery banding

OBJECTIVE

The adjustable pulmonary artery band (APAB) has been demonstrated by us earlier to be superior to the conventional pulmonary artery banding (CPAB), in terms of reduced early morbidity and mortality. In this study, we assessed the adequacy of the band and its complications over the mid-term.

METHODS

Between 2002 and 2012, 73 patients underwent adjustable PAB, and their operative and follow-up data were collected and analyzed.

RESULTS

There was one early death following the APAB. Follow-up data were available for 57 patients of which 44 patients (61.7%) underwent definitive repair, 10 were awaiting definitive repair, and 3 patients were kept on medical follow-up because of inadequate fall in pulmonary artery (PA) pressures. 14 patients (19%) were lost to follow-up. Major PA distortion or stenosis was absent in the majority. 1 patient had pseudoaneurysm of the main pulmonary artery (MPA) with sternal sinus infection and required surgical reconstruction. 1 patient had infective endocarditis of the pulmonary valve managed medically. Band migration was not encountered. There were two deaths after definitive repair and one after APAB.

CONCLUSIONS

Patients undergoing APAB fulfilled the desired objectives of the pulmonary artery banding (PAB) with minimum PA complications in the mid-term. This added to the early postoperative benefits, makes the APAB an attractive alternative to the CPAB.

Pulmonary artery debanding

Pulmonary artery banding is a simple palliative surgical procedure for congenital heart defects with left-to-right shunt or complete mixing and pulmonary over-circulation. Even though indication for pulmonary artery banding has been sensibly reduced, since early reparative surgery has been proved superior to palliation and a staged approach, an increasing support for pulmonary banding has been raised in the last two decades by new indications such as left ventricular retraining, in the late arterial switch operation for complete transposition of the great arteries or before the double-switch operation in congenitally corrected transposition. Along with the increasing interest raised by the new indications and the consequently more diffuse use of banding, debanding has become an important surgical issue. Debanding is usually performed several months after palliation along with the repair of the cardiac malformations; otherwise, it can be done progressively or partially to further delay surgery and let the patient grow. Occasionally, after pulmonary artery banding, a spontaneous resolution of the underlying cardiac malformation can occur; however, a debanding procedure is in any case necessary.

Single ventricle physiology: surgical options, indications and outcomes

PURPOSE OF REVIEW

Among the most frequently encountered congenital heart malformations are those with so-called single ventricle physiology, in which there is only one ventricle to pump blood to the pulmonary and systemic vascular beds, respectively. Long-term survival is possible, based on the principle of right heart bypass, whereby the ventricle pumps blood only to the systemic circuit, whereas pulmonary blood flow occurs passively. Such a circulatory system is achieved in a series of staged reconstructive operations, each of which was formerly accompanied by very high rates of major morbidity and mortality. Current approaches to single ventricle physiology as well as areas of controversy will be reviewed.

RECENT FINDINGS

The development of a number of inventive operations, combined with a greater understanding of the physiologic requirements for success after single ventricle reconstruction has resulted in dramatic improvements in outcomes. The identification and modification of risk factors as well as the recent development of catheter-based intervention offer the real prospect of significant continued improvement.

SUMMARY

Advances in the care of children with single ventricle hearts have resulted in remarkably improved prognosis, with the expectation of continued improvement in not only survival but also quality of life.